Migraine and Erectile Dysfunction: What the Research Shows

Migraine and Erectile Dysfunction: What the Research Shows

Marcus Reid

Marcus Reid, Medical Content Advisor

Senior Health Editor

August 6, 2026
erectile dysfunctionmigrainevascular health

Migraine and erectile dysfunction may appear unrelated, but population studies consistently report that men with migraine have higher rates of erection difficulty than men without migraine. The association does not prove that migraine directly causes erectile dysfunction (ED). It does suggest that the two conditions can share vascular, neurologic, psychological, and medication-related pathways worth evaluating—especially when symptoms are persistent or begin at a younger age.

Migraine and Erectile Dysfunction in Population Studies

Migraine is a neurologic disorder characterized by recurrent attacks that may include moderate or severe headache, nausea, sensitivity to light or sound, and, in some people, aura. ED is the persistent inability to attain or maintain an erection sufficient for satisfactory sexual activity. Both conditions are common, fluctuate over time, and are influenced by health factors that can be difficult to separate in observational research.

A 2022 systematic review and cumulative analysis brought together six studies with 51,657 participants, including 6,175 men with migraine. Compared with the general population without migraine, men with migraine had a 63% higher relative risk of ED. They also had lower average scores on the five-item International Index of Erectile Function (IIEF-5), a validated screening instrument.[1]

The review reported an especially large association in studies whose participants were younger than 40. That subgroup estimate had a very wide confidence interval and was based on limited data, so it should not be interpreted as a precise measure of individual risk. Still, it reinforces an important clinical point: erection problems in younger men should not automatically be dismissed as anxiety or lack of interest.

A nationwide Taiwanese cohort provides longitudinal evidence. Researchers matched 5,015 people with migraine to 20,060 controls and followed diagnoses over time. The migraine group had 1.78 times the adjusted hazard of being diagnosed with ED. The association remained for ED classified as organic, and it was stronger among people who also had anxiety.[2]

More recent U.S. data point in the same direction. An analysis of 3,117 adult men in the National Health and Nutrition Examination Survey found that severe headache or migraine was associated with 51% higher adjusted odds of ED. The analysis accounted for several demographic and cardiometabolic factors, but it could not fully assess depression and anxiety, two important potential confounders.[3]

These are meaningful associations, not proof of cause. Migraine may contribute to ED, ED may increase distress and headache burden, or shared conditions may increase the likelihood of both. Diagnostic-record studies can also miss men who never seek care, and cross-sectional studies cannot establish which condition appeared first.

Shared Vascular and Neurologic Pathways

An erection depends on coordinated signaling between the brain, peripheral nerves, blood vessels, smooth muscle, and pelvic floor. Sexual stimulation promotes nitric oxide release in penile tissue. This activates cyclic guanosine monophosphate, relaxes smooth muscle, increases arterial inflow, and helps restrict venous outflow. Endothelial dysfunction, reduced nitric oxide bioavailability, nerve injury, or impaired autonomic signaling can disrupt this sequence.

Migraine biology is also tied to the nervous and vascular systems, although it is not simply a disorder of dilated blood vessels. Activation of the trigeminovascular system, release of calcitonin gene-related peptide, altered sensory processing, cortical excitability, and autonomic changes all contribute. Some people with migraine also have higher rates of hypertension, insulin resistance, sleep disorders, and cardiovascular disease—conditions independently associated with ED.

Endothelial dysfunction is one proposed bridge. The endothelium controls vascular tone, inflammation, and platelet activity. When endothelial signaling is impaired, small penile arteries may have difficulty producing the rapid increase in blood flow required for erection. Studies have also described vascular and endothelial abnormalities in subsets of people with migraine, particularly migraine with aura. This overlap is biologically plausible, but current clinical research does not show that a single endothelial mechanism explains the association.

Autonomic function offers another possible link. Migraine attacks can involve nausea, sweating, pallor, dizziness, and other signs of altered autonomic activity. Erections require a shift toward parasympathetic signaling and adequate suppression of sympathetic tone. Pain, anticipatory stress, and sympathetic activation can therefore interfere with arousal and maintenance even without permanent vascular disease.

Experimental work has explored molecular pathways shared by migraine and ED, including PI3K/Akt signaling involved in nitric oxide production and vascular function. A rat model reported erectile changes alongside altered signaling in this pathway.[4] Animal and bioinformatic findings can generate hypotheses, but they cannot determine how often the same mechanism causes ED in men with migraine.

Pain, Anxiety, Sleep, and Sexual Function

Migraine affects sexual health through more than vascular biology. During an attack, pain, nausea, sensory sensitivity, fatigue, and fear of worsening symptoms can make sexual activity undesirable or impractical. Frequent attacks can create uncertainty around intimacy and reduce opportunities for relaxed sexual experiences.

Anxiety and depression are more prevalent among people with migraine, and both can affect libido, arousal, erection quality, orgasm, and relationship satisfaction. Performance anxiety activates sympathetic pathways that oppose the physiologic conditions needed for erection. Depression can reduce interest and pleasure, while some antidepressants can impair sexual function. The Taiwanese cohort's particularly strong association among participants with anxiety illustrates how these factors may interact rather than operate independently.[2]

Sleep is another shared pathway. Migraine and sleep disorders have a bidirectional relationship: insufficient sleep can trigger attacks, while pain can fragment sleep. Obstructive sleep apnea, insomnia, irregular schedules, and chronic sleep restriction are each associated with cardiometabolic strain and may contribute to ED through hormonal, vascular, and psychological mechanisms.

Relationship effects matter as well. Repeated cancellations, unpredictable symptoms, or concern that sex will trigger a headache can change communication and expectations between partners. Some people experience headache associated with sexual activity, including pain that builds with arousal or begins abruptly near orgasm. A first sudden, explosive headache during sex requires urgent evaluation to exclude bleeding or another vascular emergency. Recurrent sexual-activity headache also deserves medical assessment rather than self-diagnosis as migraine.

How Migraine Treatments Can Affect Erections and Headaches

Medication review is essential because drugs used for either condition can influence the other. Some migraine-preventive treatments, including certain beta blockers and antidepressants, may contribute to erection difficulty or reduced libido in some men. Effects vary by medication and individual, and stopping preventive therapy abruptly can worsen migraine or create other risks. A clinician can assess timing, dose, alternatives, and competing causes.

Other preventive treatments do not have a consistent ED signal, but real-world response remains individual. The key question is temporal: did sexual symptoms begin or worsen after a medication was started or increased? Even when timing aligns, the underlying migraine, anxiety, vascular risk factors, and other prescriptions must be considered before assigning cause.

Oral phosphodiesterase type 5 (PDE5) inhibitors are established first-line treatments for many men with ED. Headache is among their most common adverse effects because these medicines alter cyclic nucleotide signaling and vascular tone. In men prone to migraine, sildenafil has triggered migraine-like attacks in controlled research, while headache can occur with other agents in the class as well.[5] This does not mean men with migraine can never use ED medication, but physician supervision and an individualized discussion of prior headache patterns are important.

Treatment choice may involve dose, duration of action, other medicines, cardiovascular status, and whether headache occurs reliably after use. Men taking nitrates cannot use PDE5 inhibitors because the combination may cause a dangerous drop in blood pressure. Alpha blockers, significant hypotension, recent cardiovascular events, and some eye conditions also require careful review.

Pain relievers present different issues. Frequent use of acute headache medication can lead to medication-overuse headache. Opioids, which are generally not preferred for routine migraine care, may suppress testosterone and contribute to sexual dysfunction when used chronically. A complete medication list should include prescriptions, over-the-counter products, supplements, and recreational substances.

What Men With Both Conditions Should Discuss With a Clinician

The goal is not to decide whether migraine “caused” ED from a single visit. It is to identify modifiable contributors and select treatments that account for both conditions. A clinical assessment typically considers when ED began, whether erections occur during sleep or masturbation, whether the issue is obtaining or maintaining rigidity, migraine frequency and aura status, medication timing, relationship context, and symptoms of anxiety or depression.

Basic evaluation may include blood pressure, cardiovascular risk assessment, fasting glucose or hemoglobin A1c, lipid testing, and a morning testosterone level when symptoms suggest androgen deficiency. ED can precede recognized cardiovascular disease, so persistent symptoms should not be treated only as a sexual-performance problem. Migraine with aura may also influence vascular risk discussions, particularly in men who smoke or have uncontrolled hypertension.

Managing shared risk factors may support overall health and erectile function. Regular aerobic activity, adequate sleep, smoking cessation, weight management, and control of blood pressure and diabetes may support endothelial health. Migraine triggers differ between individuals, so overly restrictive diets or rigid trigger avoidance are rarely useful without a clear pattern. A headache diary can help identify associations among sleep, attacks, medication use, sexual symptoms, and adverse effects.

Care may involve primary care, neurology, urology, or behavioral health. Cognitive behavioral therapy and other evidence-based psychological treatments can support migraine management and reduce performance anxiety without implying that either condition is “all in the mind.” Couples counseling or sex therapy may help when pain and avoidance have affected communication.

Emergency care is appropriate for a sudden severe headache, new neurologic deficit, chest pain, fainting, or an erection lasting longer than four hours. Otherwise, prompt outpatient review is reasonable for new or persistent ED, a major change in headache pattern, or adverse effects that interfere with treatment adherence.

Conclusion

Clinical studies consistently associate migraine with a higher likelihood of ED, including a 2022 pooled analysis and a 2025 U.S. population study. The relationship is probably multifactorial: vascular risk, autonomic signaling, pain, poor sleep, anxiety, depression, and medication effects can overlap. Because the evidence is primarily observational, it cannot predict whether treating migraine alone will restore erectile function. Evaluation should address both conditions and the health factors they share.

If you're exploring clinically formulated options, OnyxMD offers physician-supervised Red Pill treatment plans starting with a free online assessment at questionnaire.getonyxmd.com. You can find additional evidence-based men's health resources in the OnyxMD blog.


These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.

References

  1. He W, Yang Y, Liang H, Huang Z, Jiang J. Migraine Is Associated With High Risk of Erectile Dysfunction: A Systematic Review and Cumulative Analysis. The Journal of Sexual Medicine. 2022;19(3):430-440. doi:10.1016/j.jsxm.2021.12.014
  2. Wu SH, Chuang E, Chuang TY, et al. A Nationwide Population-Based Cohort Study of Migraine and Organic-Psychogenic Erectile Dysfunction. Medicine. 2016;95(10):e3065. doi:10.1097/MD.0000000000003065
  3. Wu X, Zhang Y, Liu G, et al. Association between severe headache or migraine and erectile dysfunction in American adults: a cross-sectional data study from the NHANES. International Journal of Impotence Research. 2025;37(2):145-151. doi:10.1038/s41443-024-00867-w
  4. Li F, Yu X, Zhang H, et al. A Bioinformatic Investigation of the Mechanism Underlying Migraine-Induced Erectile Dysfunction. Journal of Pain Research. 2021;14:1303-1319. doi:10.2147/JPR.S301458
  5. Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126(1):241-247. doi:10.1093/brain/awg009

Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.

Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.

Marcus Reid

Written by

Marcus Reid, Medical Content Advisor

Senior Health Editor · OnyxMD Editorial Team

Marcus Reid is a senior health editor at OnyxMD with over a decade of experience covering men's sexual health, testosterone, and male vitality. He specialises in translating clinical research into practical, evidence-based guidance for men navigating their health options.